Indication research
1 drug is in development for Chronic Pain.
- Companies
- 1
- Clinical trials
- 56
BioSniper AIPage evidence connected
Prepared research question
Which programs lead the Chronic Pain pipeline—and what evidence could change the picture?
Run cited research
Traceable citations · Unknowns marked
Drug Pipeline by Phase
Approved(1)
| Drug | Company |
|---|---|
| venodol | SPOTLIGHT INNOVATION INC. (STLT) |
About this indication
Chronic Pain context
·MeSH: Chronic Pain (D059350)
Prevalence
8230.9 / 100K
Incidence
3488.0 / 100K/yr
Frequently asked questions
How many drugs are in development for Chronic Pain?
BioSniper tracks 1 drug in development for Chronic Pain across 1 company.
How many clinical trials target Chronic Pain?
There are 56 clinical trials targeting Chronic Pain tracked by BioSniper.
What is the prevalence of Chronic Pain?
The estimated prevalence of Chronic Pain is approximately 8230.9 per 100,000 population.